Nutritional approaches to cardiovascular health
Wednesday 12 October 2011
Venue: Royal Society of Medicine, 1 Wimpole Street, LONDON, W1G 0AE
We are no longer taking online registrations for this meeting.
There are still places if you wish to register on the day but lunch may not be available.
For further details please contact the coordinator.
Despite recent improvements, cardiovascular disease (CVD) remains the leading cause of death worldwide. In England and Wales CVD currently accounts for some 37% of deaths. According to the World Health Organization (WHO) up to 80% of these cases can be avoided by changing to a healthier diet, increasing physical activity and stopping smoking. As evidence to support this, a lifestyle intervention in Finland led to a 68% reduction in premature deaths from CVD in the period 1970 to 1995.
The intention of this conference is to highlight nutritional strategies targeted at cardiovascular health. These include maintenance of healthy cholesterol levels, consumption of foods and ingredients implicated in endothelial function, the maintenance of healthy blood pressure and consideration of acute postprandial effects. A broad cross-section of stakeholders will be brought together to review the latest scientific developments and to discuss future directions and implications for public health.
Audience: The meeting is intended as a briefing for general practitioners, consultants, dieticians, nutritionists and other healthcare practitioners. It will also be of interest to key stakeholders including food and ingredient companies, retailers, and, importantly, academics and students active in the field of nutrition and health.
Registration Details:
Consultant/GP: £85
RSM Student: £30
RSM Trainee: £40
RSM Associate: £50
RSM Fellow: £70
Student: £40
Trainee: £50
Food industry delegate: £85
Nurse/dietician/nutritionist: £60
9.00 am |
Registration with tea and coffee |
| Chair: Professor Julie Lovegrove, Professor of Metabolic Nutrition, Institute of Cardiovascular and Metabolic Research, University of Reading | |
9.30 am |
Welcome and introduction |
| Professor Julie Lovegrove | |
9.40 am |
Ischaemic heart disease in 2011: Pathogenesis and management |
| Professor Juan-Carlos Kaski, Professor of Cardiovascular Sciences, Head of Cardiodiovascular Research Centre, St George's University, London | |
10.10 am |
Biomarkers of cardiovascular health and disease |
| Professor Bruce Griffin, Professor of Nutritional Metabolism, University of Surrey | |
10.40 am |
Overview of the role of dietary lipids in cardiovascular disease risk |
| Professor Julie Lovegrove | |
11.10 am |
Refreshments |
11.30 am |
Overview of stanols and sterols in cholesterol management |
| Dr Sara Stanner, Science Programme Manager, British Nutrition Foundation | |
12.00 pm |
Case Study: Scientific substantiation of the heart health benefits of almonds |
| Dr Karen Lapsley, Almond Board of California | |
12.30 pm |
Oat ß-glucan may improve cardiovascular health by lowering LDL cholesterol and reducing dietary glycaemic index – the clinical evidence, regulatory and legal path |
|
Mr Ruedi Duss, Managing Director, CreaNutrition Ltd , Switzerland Professor Tom Wolever, Department of Nutritional Sciences, University of Toronto; Department of Medicine, St. Michael's Hospital, Toronto; and President, Glycemic Index Laboratories, Inc., Toronto, Canada |
|
1.00 pm |
General discussion |
1.15 pm |
Lunch |
| Chair: Professor Jonathan Gibbins, Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading | |
2.00 pm |
Evidence for the benefits of DHA in maintaining cardiovascular health |
| Professor Michael Crawford, Imperial College, London | |
2.30 pm |
Dietary polyphenos and vascular health |
| Professor Roger Corder, Professor of Experimental Therapeutics, Bart's and the London School of Medicine and Dentistry | |
3.00 pm |
Can epicatechin-rich or quercetin-rich foods be targeted for specific cardiovascular disorders |
| Dr Vincent Wilson, Associate Professor and Reader in Autonomic Pharmacology, School of Biomedical Sciences, University of Nottingham | |
3.30 pm |
Refreshments |
3.50 pm |
Role of peptides in maintaining healthy blood pressure |
|
Dr. Daniel Raederstorff, DSM Nutritional Products Ltd. R & D Human Nutrition and Health |
|
4.20 pm |
Clinical evidence for the beneficial role of whole grains for cardiovascular health |
| Professor Chris Seal, Institute for Ageing and Health, Newcastle University | |
4.50 pm |
Nutritional impact on platelet cell signalling - cell biology and mechanistics |
| Professor Jonathan Gibbins, Institute for Cardiovascular and Metabolic Research School of Biological Sciences, University of Reading | |
5.20 pm |
Fruitflow (water soluble tomato concentrate): The untrodden path from Clinical evidence to EFSA approved health claim in an area of emerging science |
| Steve Morrison, Chief Operating Officer, Provexis | |
5.50 pm |
General discussion, concluding remarks and completion of evaluation forms. |
6.10 pm |
Close of meeting |
|
Meeting ref: FHC01 CPD (Applied for) |
|